After a rocky start to the spring, Wall Street came roaring back in May. President Trump’s softened tariff stance reignited ...

Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an ...

Oppenheimer maintained its Outperform rating on Trevi Therapeutics, Inc. (NASDAQ:TRVI) shares and lifted the price target ...

Chipmaker Broadcom is set to report quarterly results after the closing bell Thursday, with Wall Street analysts expecting growing revenue and profits fueled by demand for AI.

Peter Oppenheimer, chief global equity strategist at Goldman Sachs, says the prospect of looser monetary and fiscal policy in ...

Oppenheimer analyst Rick Schafer reiterated a Buy rating on NVIDIA Corporation (NASDAQ:NVDA) and set a price target of ...

Long before blockbusters like Oppenheimer and Interstellar, Christopher Nolan directed this brilliant but overlooked thriller ...

Discover which Christopher Nolan blockbuster tops the list as his most expensive production, reaching a quarter of a billion ...

Oppenheimer analyst Christopher Glynn upped Nordson Corporation (NASDAQ:NDSN)’s stock from “Perform” to “Outperform” with a ...

Christopher Nolan is creating the first-ever movie to be shot entirely on IMAX cameras with The Odyssey, a feat that no other ...

All told, Oppenheimer analyst Rick Schafer feels good about Nvidia's positioning coming out of earnings. "The best house on the best block, \[Nvidia\] remains arguably best positioned in AI, ...